CTRI/2024/03/063737
Not yet recruiting
未知
Comparative Evaluation Of The Levels Of Biomarkers RANKL,OPG And Cementum Protein1 In Gingival Crevicular Fluid When Resin Modified Glass Ionomer And Biodentine Are Used As Barriers In Non Vital Tooth Bleaching- A Clinical Study - Yes
Dr Anwar S Pillai0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dr Anwar S Pillai
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Only patients older than 18\-years\-old with one or more non\-vital tooth with A2
- •color or darker; absence of vestibular restoration at the middle third of the tooth;
- •no apical lesion or periradicular pathology, and non\-vital tooth without any prior
- •bleaching experience
Exclusion Criteria
- •Patients who were pregnant or lactating, with hypoplasia of the enamel,
- •tetracycline staining or fluorosis, in orthodontic treatment with fixed appliances,
- •with cancer or periodontal disease or having active caries lesions were excluded
- •from the stud
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
To compare the level of a biochemical substance in the fluid around a screw after its placement and applying a force through a wire on it - An initial studyCTRI/2019/02/017791Dr HITESH
Recruiting
Not Applicable
Comparative evaluation of clinical markers indicating hypoglycaemia treated with ImeglimiN and its eFfect on erythrocytes IN patIents with TYpe 2 diabetesType 2 diabetes mellitusD003924JPRN-jRCTs031220489Osonoi Takeshi30
Recruiting
Not Applicable
Examination of the relationship between biomarkers in nasal discharge during initial wheezing and the onset of asthma in early childhoodBronchial asthmaJPRN-UMIN000044655Dokkyo Medical University Hospital148
Not yet recruiting
Phase 4
A comparison of biomarker and prosthetic complication in splinted and nonsplinted implant-supported prosthesesCTRI/2024/03/063788Dr. Divya Dharshini M
Active, not recruiting
Phase 1
Biomarkermoderate-to-severe psoriasisMedDRA version: 19.0 Level: PT Classification code 10037153 Term: Psoriasis System Organ Class: 10040785 - Skin and subcutaneous tissue disordersTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]EUCTR2015-002588-40-DEniversity Hospital Schleswig-Holstein40